By Emeritus Professor Terry Campbell

Journal articles

Campbell T, 2000, 'Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification', Cardiovascular Research, 45, pp. 55 - 56, http://dx.doi.org/10.1016/S0008-6363(99)00308-9

Campbell TJ, 2000, 'Update on the use of magnesium as an antiarrhythmic drug', Cardiac Electrophysiology Review, 4, pp. 251 - 254, http://dx.doi.org/10.1023/A:1026543431623

Walker B, 2000, 'Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel', Cardiovascular Research, 48, pp. 44 - 58, http://dx.doi.org/10.1016/s0008-6363(00)00155-3

Tonini R; Ferroni A; Valenzuela SM; Warton K; Campbell TJ; Breit SN; Mazzanti M, 2000, 'Functional characterization of the NCC27 nuclear protein in stable transfected CHO-K1 cells', FASEB JOURNAL, 14, pp. 1171 - 1178, http://dx.doi.org/10.1096/fasebj.14.9.1171

Walker BD; Tie H; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ, 2000, 'Hyperkalaemia and acidosis modify HERG channel biophysical properties and antagonise inhibition by sotalol', Heart, Lung and Circulation, 9, pp. A131 - A131, http://dx.doi.org/10.1046/j.1443-9506.2000.07650.x

Tie H; Walker BD; Singleton CB; Valenzuela SM; Bursill JA; Wyse KR; Breit SN; Campbell TJ, 2000, 'Inhibition of HERG potassium channels by the antimalarial agent halofantrine', British Journal of Pharmacology, 130, pp. 1967 - 1975, http://dx.doi.org/10.1038/sj.bjp.0703470

Singleton CB; Walker BD; Campbell TJ, 2000, 'N-3 polyunsaturated fatty acids and cardiac mortality', Australian and New Zealand Journal of Medicine, pp. 246 - 251

Singleton CB; Walker BD; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ, 2000, 'Potent blockade by quinidine of the Kv4.3 current: Significance with regard to treatment of the brugada syndrome', Heart, Lung and Circulation, 9, pp. A92 - A92, http://dx.doi.org/10.1046/j.1443-9506.2000.06115.x

Tie H; Walker BD; Singleton CB; Bursill J; Wyse K; Valenzuela S; Breit SN; Campbell TJ, 2000, 'The antipsychotic agents thioridazine, chlorpromazine and clozapine block the human-ether-a-go-go-related gene (HERG) potassium channel: Cellular mechanism for proarrhythmia', Heart, Lung and Circulation, 9, pp. A109 - A109, http://dx.doi.org/10.1046/j.1443-9506.2000.06796.x

Tie H; Walker BD; Valenzuela SM; Breit SN; Campbell TJ, 2000, 'The heart of psychotropic drug therapy', The Lancet, 355, pp. 1825 - 1825, http://dx.doi.org/10.1016/s0140-6736(05)73083-x

Valenzuela SM; Mazzanti M; Tonini R; Qiu MR; Warton K; Musgrove EA; Campbell TJ; Breit SN, 2000, 'The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle', The Journal of Physiology, 529, pp. 541 - 552, http://dx.doi.org/10.1111/j.1469-7793.2000.00541.x

Singleton CB; Valenzuela SM; Walker BD; Tie H; Wyse KR; Bursill JA; Qiu MR; Breit SN; Campbell TJ, 1999, 'Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells.', Br J Pharmacol, 127, pp. 941 - 948, http://dx.doi.org/10.1038/sj.bjp.0702638

Walker BD; Valenzuela SM; Singleton CB; Tie H; Bursill JA; Wyse KR; Qiu MR; Breit SN; Campbell TJ, 1999, 'Inhibition of HERG channels stably expressed in a mammalian cell line by the antianginal agent perhexiline maleate.', Br J Pharmacol, 127, pp. 243 - 251, http://dx.doi.org/10.1038/sj.bjp.0702502

Walker BD; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Qiu MR; Breit SN; Campbell TJ, 1999, 'Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.', Br J Pharmacol, 128, pp. 444 - 450, http://dx.doi.org/10.1038/sj.bjp.0702774

Tonkin A; Alyward P; Colquhoun D; Glasziou P; Harris P; Hunt D; Keech A; MacMahon S; Magnus P; Newel D; Nestel P; Sharpe N; Shaw J; Simes RJ; Thompson P; Thompson A; West M; White H; Simes S; Hague W; Caleo S; Hall J; Martin A; Mulray S; Barter P; Beilin L; Collins R; McNeil J; Meier P; Willimott H; Smithers D; Wallace P; Baker J; Hobbs M; Sullivan D; Anderson N; Hankey G; Watson J; Arulchelvam M; Chup S; Daly J; Hanna J; Leach A; Lee M; Loughhead J; Lundie-Jenkin H; Morrison J; Netting S; Nguyen A; Pater H; Philip R; Pinna G; Rattos D; Ryerson S; Sazhin V; Walsh R; Claque A; Mackie M; Yallop J; Boss K; Shepard M; Leach J; Gandy M; Joughin J; Seabrook J; Abraham R; Allen J; Bates F; Beinart I; Breed E; Brown D; Bunyan N; Calvert D; Campbell T; Condon-Paoloni D; Conway B; Coupland L; Crowe J; Cunio N; Cuthbert B; Cuthbert N; D'Arcy S; Davidson P; Dwyer B; England J; Friend C; Fulcher G; Grant S; Hellestrand K; Kava M; Kritharides L; McGill D; McKee H; McLean A; Neaverson M; Nelson G; O'Neill M; Onuma C; O'Reilly F, 1998, 'Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels', New England Journal of Medicine, 339, pp. 1349 - 1357, http://dx.doi.org/10.1056/NEJM199811053391902

Diaz R; Paolasso E; Piegas L; DeBono D; Heikkilä J; Neuhaus K; Toutouzas P; Ardissino D; Betriu A; Dalby A; Pfisterer M; Bates E; Gibler W; Gore J; Hochman J; Holmes D; Kleiman N; Morris D; Ohman E; Weaver W; Nicolau J; Carvalho D; Califf R; Granger C; Harrington R; Newby K; Karnash S; Peek-Hackenson M; Mabie J; Melton J; Snapp J; Brown D; Dabolt N; Greene C; McClanahan M; Strand G; Tardiff B; Winchell M; Bolte J; Evans R; Poku M; Conder S; Tinnin K; Lloyd W; Jackson G; Lee K; Bhapkar M; Sense W; Topol E; Passmore D; Konczos L; Armstrong P; Caouette S; Martin S; Sutherland W; Van de Werf F; Luyten A; Tobback L; Houbracken K; Brower R; D'Hoore L; Simes J; Keech A; Kava M; Frye R; Cheitlin M; DeMets D; Fisher L; Jeffery I; Taverner P; Walsh W; Friend C; Leitch J; Cox K; Freedman B; Gaynor M; Campbell T; D'Arcy S; Owensby D; Davidson T; Ramsey D; Quinn W; Verzosa M; Wikramanayake R; Manners G; Waites J; Cahill P; Woods J; Kearney A; Fitzpatrick D; Schoevers D; Hunt D; Sallaberger M; Federman J; Briggs H; Appelbe A; Miller M; Newman R; Peeler C; Lefkovits J, 1998, 'International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina', Circulation, 97, pp. 2386 - 2395, http://dx.doi.org/10.1161/01.CIR.97.24.2386

Martin D; Bursill J; Qui MR; Breit SN; Campbell T, 1998, 'Alternative hypothesis for efficacy of macrolides in acute coronary syndromes.', Lancet, 351, pp. 1858 - 1859, http://dx.doi.org/10.1016/S0140-6736(05)78804-8

West PD; Martin DK; Bursill JA; Wyse KR; Campbell TJ, 1998, 'Comparative study of the effects of erythromycin and roxithromycin on action potential duration and potassium currents in canine Purkinje fibers and rabbit myocardium', Journal of Cardiovascular Pharmacology and Therapeutics, 3, pp. 29 - 36, http://dx.doi.org/10.1177/107424849800300104

Campbell TJ; Williams KM, 1998, 'Therapeutic drug monitoring: Antiarrhythmic drugs', British Journal of Clinical Pharmacology, 46, pp. 307 - 319, http://dx.doi.org/10.1046/j.1365-2125.1998.t01-1-00768.x

Day RO; Williams KM; Campbell TJ, 1998, 'The death of a normal healthy volunteer in a human research project: implications for Australian clinical research', Medical Journal of Australia, 168, pp. 449 - 451, http://dx.doi.org/10.5694/j.1326-5377.1998.tb139026.x

Campbell TJ; Williams KM, 1998, 'Therapeutic Drug monitoring of antiarrhythmic drugs', British Journal of Clinical Pharmacology, pp. 307 - 319

Campbell TJ, 1997, 'Chapter 26 Antiarrhythmic drugs', Principles of Medical Biology, 8, pp. 519 - 527, http://dx.doi.org/10.1016/S1569-2582(97)80051-7

Firkin F; Campbell T, 1997, 'Safety of chloramphenicol eyedrops', Australian and New Zealand Journal of Ophthalmology, 25, pp. 3

Jan M; Martin DJ; Bursill JA; Wyse KR; Campbell TJ, 1997, 'Modulation of the electrophysiologic actions of E-4031 and dofetilide by hyperkalemia and acidosis in rabbit ventricular myocytes', Journal Cardiovascular Pharmacology and Therapentics, 2, pp. 205 - 212

Valenzuela SM; Martin DK; Por SB; Robbins JM; Warton K; Bootcov MR; Schofield PR; Campbell TJ; Breit SN, 1997, 'Molecular Cloning and Expression of a Chloride Ion Channel of Cell Nuclei', Journal of Biological Chemistry, 272, pp. 12575 - 12582, http://dx.doi.org/10.1074/jbc.272.19.12575

Nakaya Y; Martin DJ; Campbell TJ, 1997, 'The novel class 111antiarrhythymic agent MS-551 blocks the inward rectifier with greater potency than sotalol or E-4031: possible relevance to reverse use-dependence', Journal Cardiovascular Pharmacology and Therapentics, 2, pp. 39 - 46

Campbell TJ, 1997, 'The place of amiodarone: an overview of the four recent large amidarone trials', Australian and New Zealand Journal of Medicine, pp. 582 - 590

West PD; Bursill JA; Wyse KR; Martin DK; Campbell TJ, 1996, 'Effect of the class III antiarrhythmic agent E-4031 on the ATP-sensitive potassium channel in rabbit ventricular myocytes', Pharmacology and Toxicology, 78, pp. 89 - 93, http://dx.doi.org/10.1111/j.1600-0773.1996.tb00186.x

Campbell TJ, 1996, 'Proarrhythmic complications of sotalol', Australian and New Zealand Journal of Medicine, 26, pp. 147 - 149, http://dx.doi.org/10.1111/j.1445-5994.1996.tb00875.x

Campbell TJ, 1996, 'Beta-blockers for ventricular arrhythmia:have we underestimated their value?', Australian and New Zealand Journal of Medicine, pp. 689 - 696

West PD; Bursill JA; Wyse KR; Martin DJ; Campbell TJ, 1996, 'Blockade of the ATP-sensitive potassium channel in rabbit ventricular myocytes by the class III anti-arrhythmic agent E-4031', Pharmacology and Toxicology, pp. 89 - 93

Martin DJ; Boneham GC; Pirie BL; Campbell TJ; Collin HB, 1996, 'Chloride ion channels are associated with adherence of lympahatic endothelial cells', Microvascular Research, pp. 200 - 209

Pallandi RT; Lovell NH; Campbell TJ, 1996, 'Class III antiarrhythmic effects of dofetilide in rabbit atrial myocardium', Journal Cardiovascular Pharmacology and Therapentics, 1, pp. 229 - 234

Pallandi R; Lovell NH; Campbell TJ, 1996, 'Class III antiarrhythmic effects of dofetilide in rabbit atrial myocardium', Journal Cardiovascular Pharmacology and Therapentics, 1, pp. 229 - 234

Wyse KR; Bursill JA; Campbell TJ, 1996, 'Differential effects of antiarrhythmic agents on post pause repolarisation in cardiac Purkinje fibres', Clinical and Experimental Pharmacology and Physiology, pp. 825 - 829

West PD; Bursill JA; Wyse KR; Martin DJ; Campbell TJ, 1996, 'Effect of Dofetilide and d-Sotalol on the ATP-sensitive potassium channel of rabbit ventricular Myocytes', Journal Cardiovascular Pharmacology and Therapentics, pp. 307 - 312

Nakaya Y; Martin DJ; Campbell TJ, 1996, 'Effect of E-4031, sotalol and MS-551 on single inward-rectifier potassium channels in rabbit heart cells', Japanese Heart Journal, pp. 275 - 276

Campbell TJ, 1996, 'Is this Arrhythmia significant?', Australian Family Physician, pp. 1045 - 1050

Martin DK; Nakaya Y; Wyse KR; Bursill JA; West PD; Campbell TJ, 1995, 'Inhibition of ATP‐Sensitive Potassium Channels in Cardiac Myocytes by the Novel Class III Antiarrhythmic Agent MS‐551', Pharmacology Toxicology, 77, pp. 65 - 70, http://dx.doi.org/10.1111/j.1600-0773.1995.tb01915.x

Martin DJ; Bootcov MR; Campbell TJ; French PW; Breit SN, 1995, 'Human macrophages contain a stretch-sensitive potassium channel that is activated by adherence and cytokines', Journal of Membrane Biology, 147, pp. 305 - 315

Martin DJ; Nakaya Y; Wyse KR; Bursill JA; West PD; Campbell TJ, 1995, 'Inhibition of ATP-sensitive potassium channels in cardiac mycytes by a novel antiarrhymthmic agent, MS-551', Pharmacology and Toxicology, 160, pp. 202 - 205

Campbell TJ, 1994, 'Treatment of atrial fibrillation.', Australian Family Physician, 23, pp. 924 - 931

Campbell TJ, 1994, 'Antiarrhythmic drugs', Medical Journal of Australia, 160, pp. 202 - 205, http://dx.doi.org/10.5694/j.1326-5377.1994.tb126603.x

Martin DK; Nakaya Y; Wyse KR; Campbell TJ, 1994, 'Effects of disopyramide and flecainide on the kinetics of inward rectifier potassium channels in rabbit heart muscle', British Journal of Pharmacology, 111, pp. 873 - 879, http://dx.doi.org/10.1111/j.1476-5381.1994.tb14819.x

Bursill JA; Wyse KR; Campbell TJ, 1994, 'Quinidine but not disopyramide prolongs cardiac purkinje fiber action potentials after a pause', Journal of Cardiovascular Pharmacology, 23, pp. 833 - 837, http://dx.doi.org/10.1097/00005344-199405000-00021

Wyse KR; Ye V; Campbell TJ, 1993, 'Action potential prolongation exhibits simple dose-dependence for sotalol, but reverse dose-dependence for quinidine and disopyramide: Implications for proarrhythmia due to triggered activity', Journal of Cardiovascular Pharmacology, 21, pp. 316 - 322, http://dx.doi.org/10.1097/00005344-199302000-00019

Cheng TO; Campbell T; Donnan GA, 1993, 'Atrial fibrillation [7]', Medical Journal of Australia, 158, pp. 138, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137555.x

Campbell TJ, 1993, 'Class III antiarrhythmic action: The way forward?', Medical Journal of Australia, 158, pp. 732 - 733, http://dx.doi.org/10.5694/j.1326-5377.1993.tb121952.x

Campbell TJ, 1993, 'Digitalis for patients with heart failure in sinus rhythm', Medical Journal of Australia, 159, pp. 647 - 649, http://dx.doi.org/10.5694/j.1326-5377.1993.tb138076.x

Wyse KR; Ye V; Campbell TJ, 1993, 'Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea‐pig myocardium', British Journal of Pharmacology, 108, pp. 255 - 261, http://dx.doi.org/10.1111/j.1476-5381.1993.tb13471.x

Back to profile page